UnitedHealth Group (NYSE:UNH – Get Rating) had its price target increased by investment analysts at Credit Suisse Group from $590.00 to $610.00 in a report released on Wednesday, The Fly reports. The firm currently has an "outperform" rating on the healthcare conglomerate's stock. Credit Suisse Group's price target indicates a potential upside of 11.33% from the stock's current price.

A number of other research firms have also recently weighed in on UNH. SVB Leerink decreased their price objective on UnitedHealth Group from $625.00 to $618.00 and set an "outperform" rating for the company in a research report on Monday, October 17th. StockNews.com began coverage on UnitedHealth Group in a research report on Wednesday, October 12th. They set a "strong-buy" rating for the company. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $569.00 to $615.00 and gave the company a "buy" rating in a report on Tuesday, October 18th. Morgan Stanley reissued an "overweight" rating and issued a $587.00 price target on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Finally, Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, August 10th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.16.

UnitedHealth Group Trading Up 0.9 %

NYSE:UNH opened at $547.92 on Wednesday. The stock's 50 day moving average price is $528.87 and its 200 day moving average price is $519.56. The company has a market capitalization of $511.95 billion, a PE ratio of 26.83, a P/E/G ratio of 1.69 and a beta of 0.73. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a 52-week low of $445.73 and a 52-week high of $558.10.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 616 shares of UnitedHealth Group stock in a transaction on Friday, December 2nd. The stock was sold at an average price of $535.00, for a total value of $329,560.00. Following the completion of the sale, the executive vice president now owns 8,463 shares of the company's stock, valued at $4,527,705. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Axiom Financial Strategies LLC acquired a new position in UnitedHealth Group in the first quarter valued at $210,000. McGowan Group Asset Management Inc. boosted its holdings in UnitedHealth Group by 8.9% in the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate's stock valued at $379,000 after acquiring an additional 61 shares during the last quarter. Jackson Hole Capital Partners LLC boosted its holdings in UnitedHealth Group by 12.5% in the first quarter. Jackson Hole Capital Partners LLC now owns 586 shares of the healthcare conglomerate's stock valued at $299,000 after acquiring an additional 65 shares during the last quarter. One Plus One Wealth Management LLC boosted its holdings in UnitedHealth Group by 12.7% in the first quarter. One Plus One Wealth Management LLC now owns 924 shares of the healthcare conglomerate's stock valued at $471,000 after acquiring an additional 104 shares during the last quarter. Finally, First Business Financial Services Inc. boosted its holdings in UnitedHealth Group by 6.1% in the first quarter. First Business Financial Services Inc. now owns 4,231 shares of the healthcare conglomerate's stock valued at $2,158,000 after acquiring an additional 242 shares during the last quarter. Hedge funds and other institutional investors own 87.25% of the company's stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

• Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
• Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
• This Is Why Daktronics Fell 40% In One Day
• Is It Time To Throw In The Towel On Gamestop?
• Why You Should Avoid Carvana Even if it Avoids Bankruptcy
• Are Investors Hearing The End Of Spotify's Downtrend?

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.